ID   S12A5_HUMAN             Reviewed;        1139 AA.
AC   Q9H2X9; A2RTX2; Q5VZ41; Q9H4Z0; Q9ULP4;
DT   13-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 3.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Solute carrier family 12 member 5;
DE   AltName: Full=Electroneutral potassium-chloride cotransporter 2;
DE   AltName: Full=K-Cl cotransporter 2;
DE            Short=hKCC2;
DE   AltName: Full=Neuronal K-Cl cotransporter;
GN   Name=SLC12A5; Synonyms=KCC2, KIAA1176;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=12106695; DOI=10.1016/S0169-328X(02)00190-0;
RA   Song L., Mercado A., Vazquez N., Xie Q., Desai R., George A.L. Jr.,
RA   Gamba G., Mount D.B.;
RT   "Molecular, functional, and genomic characterization of human KCC2,
RT   the neuronal K-Cl cotransporter.";
RL   Brain Res. Mol. Brain Res. 103:91-105(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-175 (ISOFORM 1).
RX   PubMed=16344560; DOI=10.1101/gr.4039406;
RA   Kimura K., Wakamatsu A., Suzuki Y., Ota T., Nishikawa T.,
RA   Yamashita R., Yamamoto J., Sekine M., Tsuritani K., Wakaguri H.,
RA   Ishii S., Sugiyama T., Saito K., Isono Y., Irie R., Kushida N.,
RA   Yoneyama T., Otsuka R., Kanda K., Yokoi T., Kondo H., Wagatsuma M.,
RA   Murakawa K., Ishida S., Ishibashi T., Takahashi-Fujii A., Tanase T.,
RA   Nagai K., Kikuchi H., Nakai K., Isogai T., Sugano S.;
RT   "Diversification of transcriptional modulation: large-scale
RT   identification and characterization of putative alternative promoters
RT   of human genes.";
RL   Genome Res. 16:55-65(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-1109 (ISOFORM 2), AND
RP   VARIANT LEU-1100.
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [6]
RP   ENZYME REGULATION.
RX   PubMed=21613606; DOI=10.1152/ajpcell.00070.2011;
RA   Cruz-Rangel S., Melo Z., Vazquez N., Meade P., Bobadilla N.A.,
RA   Pasantes-Morales H., Gamba G., Mercado A.;
RT   "Similar Effects of all WNK3 Variants upon SLC12 Cotransporters.";
RL   Am. J. Physiol. 301:C601-C608(2011).
RN   [7]
RP   FUNCTION, INVOLVEMENT IN EIG14, VARIANT EIG14 HIS-975, AND
RP   CHARACTERIZATION OF VARIANT EIG14 HIS-975.
RX   PubMed=24668262; DOI=10.1002/embr.201438749;
RA   Puskarjov M., Seja P., Heron S.E., Williams T.C., Ahmad F., Iona X.,
RA   Oliver K.L., Grinton B.E., Vutskits L., Scheffer I.E., Petrou S.,
RA   Blaesse P., Dibbens L.M., Berkovic S.F., Kaila K.;
RT   "A variant of KCC2 from patients with febrile seizures impairs
RT   neuronal Cl- extrusion and dendritic spine formation.";
RL   EMBO Rep. 15:723-729(2014).
RN   [8]
RP   INVOLVEMENT IN EIEE34, VARIANTS EIEE34 HIS-311; PRO-426 AND ASP-551,
RP   AND CHARACTERIZATION OF VARIANTS EIEE34 HIS-311; PRO-426 AND ASP-551.
RX   PubMed=26333769; DOI=10.1038/ncomms9038;
RA   Stoedberg T., McTague A., Ruiz A.J., Hirata H., Zhen J., Long P.,
RA   Farabella I., Meyer E., Kawahara A., Vassallo G., Stivaros S.M.,
RA   Bjursell M.K., Stranneheim H., Tigerschioeld S., Persson B.,
RA   Bangash I., Das K., Hughes D., Lesko N., Lundeberg J., Scott R.C.,
RA   Poduri A., Scheffer I.E., Smith H., Gissen P., Schorge S., Reith M.E.,
RA   Topf M., Kullmann D.M., Harvey R.J., Wedell A., Kurian M.A.;
RT   "Mutations in SLC12A5 in epilepsy of infancy with migrating focal
RT   seizures.";
RL   Nat. Commun. 6:8038-8038(2015).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-847.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [10]
RP   INVOLVEMENT IN EIG14, VARIANTS EIG14 HIS-975 AND CYS-1072, AND
RP   CHARACTERIZATION OF VARIANTS EIG14 HIS-975 AND CYS-1072.
RX   PubMed=24928908; DOI=10.15252/embr.201438840;
RA   Kahle K.T., Merner N.D., Friedel P., Silayeva L., Liang B., Khanna A.,
RA   Shang Y., Lachance-Touchette P., Bourassa C., Levert A., Dion P.A.,
RA   Walcott B., Spiegelman D., Dionne-Laporte A., Hodgkinson A.,
RA   Awadalla P., Nikbakht H., Majewski J., Cossette P., Deeb T.Z.,
RA   Moss S.J., Medina I., Rouleau G.A.;
RT   "Genetically encoded impairment of neuronal KCC2 cotransporter
RT   function in human idiopathic generalized epilepsy.";
RL   EMBO Rep. 15:766-774(2014).
RN   [11]
RP   VARIANT TRP-1071, AND VARIANTS EIG14 HIS-975 AND CYS-1072.
RX   PubMed=26528127; DOI=10.3389/fncel.2015.00386;
RA   Merner N.D., Chandler M.R., Bourassa C., Liang B., Khanna A.R.,
RA   Dion P., Rouleau G.A., Kahle K.T.;
RT   "Regulatory domain or CpG site variation in SLC12A5, encoding the
RT   chloride transporter KCC2, in human autism and schizophrenia.";
RL   Front. Cell. Neurosci. 9:386-386(2015).
CC   -!- FUNCTION: Mediates electroneutral potassium-chloride cotransport
CC       in mature neurons and is required for neuronal Cl(-) homeostasis.
CC       As major extruder of intracellular chloride, it establishes the
CC       low neuronal Cl(-) levels required for chloride influx after
CC       binding of GABA-A and glycine to their receptors, with subsequent
CC       hyperpolarization and neuronal inhibition (By similarity).
CC       Involved in the regulation of dendritic spine formation and
CC       maturation (PubMed:24668262). {ECO:0000250|UniProtKB:Q63633,
CC       ECO:0000269|PubMed:24668262}.
CC   -!- ENZYME REGULATION: Inhibited by WNK3.
CC       {ECO:0000269|PubMed:21613606}.
CC   -!- SUBUNIT: Homomultimer and heteromultimer with other K-Cl
CC       cotransporters. Interacts with AP2A1 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=KCC2a;
CC         IsoId=Q9H2X9-1; Sequence=Displayed;
CC       Name=2; Synonyms=KCC2b;
CC         IsoId=Q9H2X9-2; Sequence=VSP_029909;
CC         Note=Ref.1 (AAG43493) sequence is in conflict in position:
CC         2:L->P. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Brain specific. Detected in neuronal cells.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 34 (EIEE34)
CC       [MIM:616645]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. EIEE34 is
CC       characterized by onset of refractory migrating focal seizures in
CC       infancy. Affected children show developmental regression and are
CC       severely impaired globally. {ECO:0000269|PubMed:26333769}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Epilepsy, idiopathic generalized 14 (EIG14) [MIM:616685]:
CC       An autosomal dominant form of idiopathic generalized epilepsy, a
CC       disorder characterized by recurring generalized seizures in the
CC       absence of detectable brain lesions and/or metabolic
CC       abnormalities. Generalized seizures arise diffusely and
CC       simultaneously from both hemispheres of the brain. Seizure types
CC       include juvenile myoclonic seizures, absence seizures, and
CC       generalized tonic-clonic seizures. {ECO:0000269|PubMed:24668262,
CC       ECO:0000269|PubMed:24928908, ECO:0000269|PubMed:26528127}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Inhibited by furosemide and bumetanide.
CC   -!- SIMILARITY: Belongs to the SLC12A transporter family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF208159; AAG43493.1; -; mRNA.
DR   EMBL; AL162458; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC132668; AAI32669.1; -; mRNA.
DR   EMBL; BC132670; AAI32671.1; -; mRNA.
DR   EMBL; AB033002; BAA86490.1; -; mRNA.
DR   EMBL; DA102113; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; DA328785; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS13391.1; -. [Q9H2X9-2]
DR   CCDS; CCDS46610.1; -. [Q9H2X9-1]
DR   RefSeq; NP_001128243.1; NM_001134771.1. [Q9H2X9-1]
DR   RefSeq; NP_065759.1; NM_020708.4. [Q9H2X9-2]
DR   UniGene; Hs.21413; -.
DR   ProteinModelPortal; Q9H2X9; -.
DR   BioGrid; 121538; 2.
DR   STRING; 9606.ENSP00000387694; -.
DR   BindingDB; Q9H2X9; -.
DR   ChEMBL; CHEMBL1615384; -.
DR   DrugBank; DB00887; Bumetanide.
DR   DrugBank; DB00761; Potassium Chloride.
DR   GuidetoPHARMACOLOGY; 972; -.
DR   TCDB; 2.A.30.5.6; the cation-chloride cotransporter (ccc) family.
DR   iPTMnet; Q9H2X9; -.
DR   PhosphoSitePlus; Q9H2X9; -.
DR   SwissPalm; Q9H2X9; -.
DR   BioMuta; SLC12A5; -.
DR   DMDM; 161784306; -.
DR   MaxQB; Q9H2X9; -.
DR   PaxDb; Q9H2X9; -.
DR   PeptideAtlas; Q9H2X9; -.
DR   PRIDE; Q9H2X9; -.
DR   Ensembl; ENST00000243964; ENSP00000243964; ENSG00000124140. [Q9H2X9-2]
DR   Ensembl; ENST00000454036; ENSP00000387694; ENSG00000124140. [Q9H2X9-1]
DR   GeneID; 57468; -.
DR   KEGG; hsa:57468; -.
DR   UCSC; uc002xrb.3; human. [Q9H2X9-1]
DR   CTD; 57468; -.
DR   DisGeNET; 57468; -.
DR   GeneCards; SLC12A5; -.
DR   HGNC; HGNC:13818; SLC12A5.
DR   HPA; HPA072058; -.
DR   MalaCards; SLC12A5; -.
DR   MIM; 606726; gene.
DR   MIM; 616645; phenotype.
DR   MIM; 616685; phenotype.
DR   neXtProt; NX_Q9H2X9; -.
DR   OpenTargets; ENSG00000124140; -.
DR   PharmGKB; PA37814; -.
DR   eggNOG; KOG2082; Eukaryota.
DR   eggNOG; COG0531; LUCA.
DR   GeneTree; ENSGT00760000119053; -.
DR   HOGENOM; HOG000092644; -.
DR   HOVERGEN; HBG052852; -.
DR   InParanoid; Q9H2X9; -.
DR   KO; K14427; -.
DR   OMA; GWPRNWR; -.
DR   OrthoDB; EOG091G0WB4; -.
DR   PhylomeDB; Q9H2X9; -.
DR   TreeFam; TF313657; -.
DR   Reactome; R-HSA-426117; Cation-coupled Chloride cotransporters.
DR   GeneWiki; Chloride_potassium_symporter_5; -.
DR   GenomeRNAi; 57468; -.
DR   PRO; PR:Q9H2X9; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124140; -.
DR   CleanEx; HS_SLC12A5; -.
DR   ExpressionAtlas; Q9H2X9; baseline and differential.
DR   Genevisible; Q9H2X9; HS.
DR   GO; GO:0043198; C:dendritic shaft; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015108; F:chloride transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0022820; F:potassium ion symporter activity; IBA:GO_Central.
DR   GO; GO:0015379; F:potassium:chloride symporter activity; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0030644; P:cellular chloride ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0006873; P:cellular ion homeostasis; NAS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0060996; P:dendritic spine development; IDA:UniProtKB.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0040040; P:thermosensory behavior; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; NAS:UniProtKB.
DR   InterPro; IPR004841; AA-permease/SLC12A_dom.
DR   InterPro; IPR030358; KCC2.
DR   InterPro; IPR000076; KCL_cotranspt.
DR   InterPro; IPR018491; SLC12_C.
DR   InterPro; IPR004842; SLC12A_fam.
DR   PANTHER; PTHR11827:SF89; PTHR11827:SF89; 1.
DR   Pfam; PF00324; AA_permease; 2.
DR   Pfam; PF03522; SLC12; 3.
DR   PRINTS; PR01081; KCLTRNSPORT.
DR   TIGRFAMs; TIGR00930; 2a30; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation; Epilepsy;
KW   Glycoprotein; Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Potassium; Potassium transport; Reference proteome; Symport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1139       Solute carrier family 12 member 5.
FT                                /FTId=PRO_0000178034.
FT   TOPO_DOM      1    133       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    134    154       Helical. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical. {ECO:0000255}.
FT   TOPO_DOM    177    194       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    195    215       Helical. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255}.
FT   TOPO_DOM    238    254       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    255    275       Helical. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical. {ECO:0000255}.
FT   TOPO_DOM    299    418       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    419    439       Helical. {ECO:0000255}.
FT   TRANSMEM    459    479       Helical. {ECO:0000255}.
FT   TOPO_DOM    480    496       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    497    517       Helical. {ECO:0000255}.
FT   TRANSMEM    570    590       Helical. {ECO:0000255}.
FT   TOPO_DOM    591    630       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    631    651       Helical. {ECO:0000255}.
FT   TRANSMEM    848    868       Helical. {ECO:0000255}.
FT   TOPO_DOM    869   1139       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      57     57       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q63633}.
FT   MOD_RES    1045   1045       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91V14}.
FT   MOD_RES    1048   1048       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91V14}.
FT   MOD_RES    1049   1049       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91V14}.
FT   CARBOHYD    442    442       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    833    833       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     40       MSRRFTVTSLPPAGPARSPDPESRRHSVADPRHLPGEDVK
FT                                -> MLNNLTDCEDGDGGANP (in isoform 2).
FT                                {ECO:0000303|PubMed:10574461,
FT                                ECO:0000303|PubMed:12106695,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029909.
FT   VARIANT     311    311       L -> H (in EIEE34; results in reduced
FT                                chloride transport; decreased
FT                                localization at the cell surface;
FT                                dbSNP:rs863225306).
FT                                {ECO:0000269|PubMed:26333769}.
FT                                /FTId=VAR_075078.
FT   VARIANT     407    407       P -> A (in dbSNP:rs16985442).
FT                                /FTId=VAR_027414.
FT   VARIANT     426    426       L -> P (in EIEE34; results in loss of
FT                                chloride transport; decreased
FT                                localization at the cell surface;
FT                                dbSNP:rs863225304).
FT                                {ECO:0000269|PubMed:26333769}.
FT                                /FTId=VAR_075079.
FT   VARIANT     551    551       G -> D (in EIEE34; results in loss of
FT                                chloride transport; decreased
FT                                localization at the cell surface;
FT                                dbSNP:rs863225305).
FT                                {ECO:0000269|PubMed:26333769}.
FT                                /FTId=VAR_075080.
FT   VARIANT     847    847       G -> D (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036557.
FT   VARIANT     975    975       R -> H (in EIG14; rare variant associated
FT                                with disease susceptibility; results in
FT                                reduced chloride transport; decreased
FT                                localization at the cell surface; unable
FT                                to induce cortical dendritic spines
FT                                formation; dbSNP:rs142740233).
FT                                {ECO:0000269|PubMed:24668262,
FT                                ECO:0000269|PubMed:24928908,
FT                                ECO:0000269|PubMed:26528127}.
FT                                /FTId=VAR_075081.
FT   VARIANT    1071   1071       R -> W (in dbSNP:rs369042030).
FT                                {ECO:0000269|PubMed:26528127}.
FT                                /FTId=VAR_075082.
FT   VARIANT    1072   1072       R -> C (in EIG14; rare variant associated
FT                                with disease susceptibility; results in
FT                                reduced chloride transport;
FT                                dbSNP:rs548424453).
FT                                {ECO:0000269|PubMed:24928908,
FT                                ECO:0000269|PubMed:26528127}.
FT                                /FTId=VAR_075083.
FT   VARIANT    1100   1100       P -> L (in dbSNP:rs17297532).
FT                                {ECO:0000269|PubMed:10574461}.
FT                                /FTId=VAR_024994.
SQ   SEQUENCE   1139 AA;  126184 MW;  100C097AF1FD4B3E CRC64;
     MSRRFTVTSL PPAGPARSPD PESRRHSVAD PRHLPGEDVK GDGNPKESSP FINSTDTEKG
     KEYDGKNMAL FEEEMDTSPM VSSLLSGLAN YTNLPQGSRE HEEAENNEGG KKKPVQAPRM
     GTFMGVYLPC LQNIFGVILF LRLTWVVGIA GIMESFCMVF ICCSCTMLTA ISMSAIATNG
     VVPAGGSYYM ISRSLGPEFG GAVGLCFYLG TTFAGAMYIL GTIEILLAYL FPAMAIFKAE
     DASGEAAAML NNMRVYGTCV LTCMATVVFV GVKYVNKFAL VFLGCVILSI LAIYAGVIKS
     AFDPPNFPIC LLGNRTLSRH GFDVCAKLAW EGNETVTTRL WGLFCSSRFL NATCDEYFTR
     NNVTEIQGIP GAASGLIKEN LWSSYLTKGV IVERSGMTSV GLADGTPIDM DHPYVFSDMT
     SYFTLLVGIY FPSVTGIMAG SNRSGDLRDA QKSIPTGTIL AIATTSAVYI SSVVLFGACI
     EGVVLRDKFG EAVNGNLVVG TLAWPSPWVI VIGSFFSTCG AGLQSLTGAP RLLQAISRDG
     IVPFLQVFGH GKANGEPTWA LLLTACICEI GILIASLDEV APILSMFFLM CYMFVNLACA
     VQTLLRTPNW RPRFRYYHWT LSFLGMSLCL ALMFICSWYY ALVAMLIAGL IYKYIEYRGA
     EKEWGDGIRG LSLSAARYAL LRLEEGPPHT KNWRPQLLVL VRVDQDQNVV HPQLLSLTSQ
     LKAGKGLTIV GSVLEGTFLE NHPQAQRAEE SIRRLMEAEK VKGFCQVVIS SNLRDGVSHL
     IQSGGLGGLQ HNTVLVGWPR NWRQKEDHQT WRNFIELVRE TTAGHLALLV TKNVSMFPGN
     PERFSEGSID VWWIVHDGGM LMLLPFLLRH HKVWRKCKMR IFTVAQMDDN SIQMKKDLTT
     FLYHLRITAE VEVVEMHESD ISAYTYEKTL VMEQRSQILK QMHLTKNERE REIQSITDES
     RGSIRRKNPA NTRLRLNVPE ETAGDSEEKP EEEVQLIHDQ SAPSCPSSSP SPGEEPEGEG
     ETDPEKVHLT WTKDKSVAEK NKGPSPVSSE GIKDFFSMKP EWENLNQSNV RRMHTAVRLN
     EVIVKKSRDA KLVLLNMPGP PRNRNGDENY MEFLEVLTEH LDRVMLVRGG GREVITIYS
//
